Samuel Lanyon
Good morning, everyone. My name is Sam Lanyon, Chair of Lumos Diagnostics Holdings Limited, and it is my pleasure to welcome you all to our Annual General Meeting of Shareholders. I’d like to start by acknowledging and paying respect to the traditional custodians of the land wherever those participating at this meeting are located.
Today’s meeting is being held in a virtual format, allowing shareholders and their representatives to participate via the webinar forum. And as such, we may experience some time lag, and this may cause delay in your questions or comments coming to our attention.
I further advised that the company has complied with the relevant requirements for convened meeting and that a quorum is present. Time is around 9:32 a.m., and I formally declare the meeting open. I’m joined through the webcast today by my fellow directors, Managing Director and CEO, Doug Ward; and our Non-Executive Directors, Catherine Robson, Bronwyn Le Grice and Lawrence Mehren. Our audit partner, Alan Finnis, representing William Buck, our external audit partner is also in attendance and will make himself available during the meeting to answer any questions on the FY ’25 audit at the appropriate time.
Also, our CFO, Barrie Lambert; and Company Secretary, Tracy Weimar are also in attendance today. The Notice of Meeting has been given in accordance with the company’s constitution, and copies are available for you on the company’s website and the share registry’s online voting site. Unless there are any objections, I intend to take the notice of this meeting, attached explanatory statement and the addendum to the Notice of Meeting sent to shareholders as read.
